WALTHAM, Mass. — BostonGene announced that Nathan Fowler, MD, Chief Medical Officer, will deliver multiple presentations at the upcoming Precision Medicine World Conference 2026, scheduled for March 4–6 in Santa Clara, Calif., where the company plans to highlight how artificial intelligence foundation models and integrated multiomics are being applied to cancer care and drug development.
BostonGene, which develops AI-driven models focused on tumor and immune biology, said its sessions will explore how multi-modal data and advanced analytics can help address the complexity of the tumor microenvironment and support more personalized oncology strategies.
Throughout the conference, the company will participate in discussions with academic and industry leaders on the evolving role of the tumor microenvironment and next-generation biomarkers in guiding treatment decisions and therapeutic development.
Dr. Fowler is slated to deliver a featured presentation on the use of multi-modal AI in drug discovery and development. He will also participate in expert panels focused on immunotherapy combinations, biomarker strategies, and approaches to overcoming resistance in cancer treatment.
“The challenge in modern oncology is no longer a lack of data, but rather the ability to synthesize vast amounts of biological information into a coherent clinical strategy,” said Dr. Fowler at BostonGene. “At PMWC, we look forward to discussing how AI-driven models can decode the complexities of the tumor microenvironment, helping the scientific community move toward more predictable and personalized treatment outcomes.”
Conference sessions featuring BostonGene include an AI and data science showcase examining how deep learning and multiomic data can provide a comprehensive view of tumors and their immune landscape to enable more precise therapy selection. Additional panels will address combination immunotherapies, the role of biomarkers in overcoming treatment resistance, and strategies for targeting the tumor microenvironment in clinical practice.
The Precision Medicine World Conference is widely regarded as a leading forum for healthcare, biotechnology, and regulatory stakeholders, focused on advancing the adoption of personalized medicine and translating molecular research into clinical practice.
